Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    May 2026
  1. MURATANI T, Iwashima K, Sakamoto F, Ishibashi R, et al
    Differential roles of ATM and Chk2 in cold atmospheric helium plasma-induced cell death in Molt-4 human leukemia cell with intact or reduced p53 expression.
    Biochem Biophys Res Commun. 2026;821:153843.
    PubMed     Abstract available


    April 2026
  2. LI W, Sun M, Yao B, Li X, et al
    FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse.
    Biochem Biophys Res Commun. 2026;809:153493.
    PubMed     Abstract available


  3. OPYDO M, Wojtaszek M, Mosurek A, Burczyk G, et al
    Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells.
    Biochem Biophys Res Commun. 2026;817:153752.
    PubMed     Abstract available


    March 2026
  4. CHEN CW, Lin YF, Yeh YY, Huang NK, et al
    Dual-specificity phosphatase 21 enhances the sensitivity of imatinib-resistant chronic myeloid leukemia cells to ponatinib through GATA-1-mediated erythroid differentiation.
    Biochem Biophys Res Commun. 2026;814:153646.
    PubMed     Abstract available


    February 2026
  5. ZHANG W, Liu Y, Xiao X, Zheng Q, et al
    Multi-scale transcriptomics analysis reveals MHC suppression in MEF2D fusion positive B-cell acute lymphoblastic leukemia.
    Biochem Biophys Res Commun. 2026;800:153274.
    PubMed     Abstract available


    January 2026
  6. WANG B, Wang HL, Ye YF, Song JZ, et al
    Ferroptosis regulation and acute leukemia: Mechanisms and therapeutic perspectives.
    Biochem Biophys Res Commun. 2026;800:153284.
    PubMed     Abstract available


    December 2025
  7. TANG BJ, Chen L, Huang ST, Zhong AN, et al
    Exosomal circ_0058493 promotes imatinib resistance via miR-548b-3p/U2SURP axis in CML cells.
    Biochem Biophys Res Commun. 2025;793:153012.
    PubMed     Abstract available


  8. SINGH P, Singh VK, Verma M
    Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches.
    Biochem Biophys Res Commun. 2025;796:153115.
    PubMed     Abstract available


    November 2025
  9. SHIMURA R, Yamamoto K, Chang YH, Otaki A, et al
    Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.
    Biochem Biophys Res Commun. 2025;793:153002.
    PubMed     Abstract available


  10. MU R, Pei X, Xu N, Liu B, et al
    Regorafenib promotes ferroptosis in acute myeloid leukemia by upregulating NOX4.
    Biochem Biophys Res Commun. 2025;792:152981.
    PubMed     Abstract available


  11. TORRES-LOPEZ L, Olivas-Aguirre M, Castellanos-Martinez R, Jimenez-Camacho KE, et al
    Voltage-dependent Kv1.3 potassium channels in the plasma membrane of acute lymphoblastic leukemic B-cells are non-conductive.
    Biochem Biophys Res Commun. 2025;787:152771.
    PubMed     Abstract available


    August 2025
  12. SANSACAR M, Pepe NA, Gencer Akcok EB, El Khatib M, et al
    Efficacy of combinatorial inhibition of Hedgehog and autophagy pathways on the survival of AML cell lines.
    Biochem Biophys Res Commun. 2025;775:152034.
    PubMed     Abstract available


    July 2025
  13. ZHANG X, Zhong L, Zhai L, Li H, et al
    IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway.
    Biochem Biophys Res Commun. 2025;772:152064.
    PubMed     Abstract available


  14. KOYAMA D, Yamamoto N, Abe T, Suzuki K, et al
    Novel insights into the ULK2-FIP200-AMPK-mediated regulation of autophagy and BCR::ABL degradation in chronic myeloid leukemia.
    Biochem Biophys Res Commun. 2025;778:152343.
    PubMed     Abstract available


    May 2025
  15. LI X, Di S, Nie F, Meng W, et al
    RPS15a knockdown impedes the progression of B-ALL by inducing p53-mediated nucleolar stress.
    Biochem Biophys Res Commun. 2025;763:151768.
    PubMed     Abstract available


  16. XIMEI WU, Lin C, Wang H, Gao J, et al
    Connectivity-map unveils Gemcitabine's efficacy in overcoming nelarabine resistance in T-cell acute lymphoblastic leukemia.
    Biochem Biophys Res Commun. 2025;769:151971.
    PubMed     Abstract available


    April 2025
  17. FAUZI YR, Nakahata S, Shimoda K, Matsuura T, et al
    Anti-transferrin receptor antibody (JST-TFR09/PPMX-T003) induces ferroptosis in adult T-cell leukemia/lymphoma (ATLL) cells.
    Biochem Biophys Res Commun. 2025;756:151564.
    PubMed     Abstract available


    March 2025
  18. YANG Y, Li Z, Zhang J, Qi H, et al
    Engineering thermostable friend mouse leukemia virus reverse transcriptase through mutational combination.
    Biochem Biophys Res Commun. 2025;760:151716.
    PubMed     Abstract available


  19. ROUSSET C, Neplaz R, Catal P, Chatre E, et al
    Correlation-based nanometric localization using lattice SIM(2) and dSTORM in PML nuclear bodies validated by calibration spheres.
    Biochem Biophys Res Commun. 2025;752:151450.
    PubMed     Abstract available


    December 2024
  20. SAWAI S, Oda Y, Saito Y, Kuwabara T, et al
    Analysis of synthetic polymer hydrogel-based generation of leukemia stem cells.
    Biochem Biophys Res Commun. 2024;744:151149.
    PubMed     Abstract available


    November 2024
  21. SHARIPOV RR, Surin AM, Silonov SA, Smirnov EY, et al
    Promyelocytic leukemia protein (PML) knockout increases mitochondrial Ca(2+) uptake in HeLa cells.
    Biochem Biophys Res Commun. 2024;739:150990.
    PubMed     Abstract available


    September 2024
  22. WANG M, Deng Q, Zhang W, Qi Q, et al
    Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors.
    Biochem Biophys Res Commun. 2024;733:150653.
    PubMed     Abstract available


    August 2024
  23. FENG X, Luo F, Wang S, Zhu F, et al
    Chidamide induces cell cycle arrest via NR4A3/P21 axis upregulation to suppress relapsed and refractory acute myeloid leukemia.
    Biochem Biophys Res Commun. 2024;737:150493.
    PubMed     Abstract available


    June 2024
  24. NAM H, Kim D, Jin X, Park S, et al
    Metabolic determinants of leukemia onset variability in genetically homogeneous AKR mice.
    Biochem Biophys Res Commun. 2024;725:150257.
    PubMed     Abstract available


  25. LIU C, Wang Y, Shi M, Tao X, et al
    hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.
    Biochem Biophys Res Commun. 2024;724:150221.
    PubMed     Abstract available


    May 2024
  26. ZHANG S, Lou S, Bian W, Liu J, et al
    Selective eradication of venetoclax-resistant monocytic acute myeloid leukemia with iron oxide nanozymes.
    Biochem Biophys Res Commun. 2024;719:150117.
    PubMed     Abstract available


    January 2024
  27. SUZUKI S, Liu J, Sato Y, Miyake R, et al
    Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells.
    Biochem Biophys Res Commun. 2024;710:149541.
    PubMed     Abstract available


    November 2023
  28. LYSIKOVA DV, Vasileva VY, Chubinskiy-Nadezhdin VI, Morachevskaya EA, et al
    Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells.
    Biochem Biophys Res Commun. 2023;687:149187.
    PubMed     Abstract available


    October 2023
  29. NIU F, Yang R, Feng H, Liu Y, et al
    A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction.
    Biochem Biophys Res Commun. 2023;684:149125.
    PubMed     Abstract available


    September 2023
  30. DENG Y, Cheng Q, He J
    HDAC inhibitors: Promising agents for leukemia treatment.
    Biochem Biophys Res Commun. 2023;680:61-72.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum